Barry G. Arnason to Humans
This is a "connection" page, showing publications Barry G. Arnason has written about Humans.
Connection Strength
0.360
-
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler. 2013 Feb; 19(2):130-6.
Score: 0.015
-
MS Forum/MS Over the Past 17 Years. Int MS J. 2011 Sep; 17(3):76-82.
Score: 0.013
-
Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale. Int MS J. 2011 May; 17(2):63-8.
Score: 0.013
-
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler. 2010 Jan; 16(1):30-8.
Score: 0.012
-
Terbutaline in myasthenia gravis: a pilot study. J Neurol Sci. 2009 Feb 15; 277(1-2):150-4.
Score: 0.011
-
Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis. J Neurol. 2005 Sep; 252 Suppl 3:iii28-iii33.
Score: 0.009
-
Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors. Protein Expr Purif. 2001 Apr; 21(3):446-55.
Score: 0.007
-
Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. Arch Neurol. 2001 Jan; 58(1):87-90.
Score: 0.006
-
Interactions between the sympathetic nervous system and the immune system. Brain Behav Immun. 1999 Dec; 13(4):271-8.
Score: 0.006
-
Interferon-ß corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine. 2019 Nov; 49:269-283.
Score: 0.006
-
Treatment of multiple sclerosis with interferon beta. Biomed Pharmacother. 1999 Sep; 53(8):344-50.
Score: 0.006
-
Immunologic therapy of multiple sclerosis. Annu Rev Med. 1999; 50:291-302.
Score: 0.006
-
Correlation of the appearance of anti-interferon antibodies during treatment and dimunition of efficacy: summary of an International Workshop on Anti-Interferon Antibodies. J Interferon Cytokine Res. 1998 Aug; 18(8):639-44.
Score: 0.005
-
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Mult Scler. 2019 04; 25(4):565-573.
Score: 0.005
-
All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Arch Neurol. 1998 Mar; 55(3):315-21.
Score: 0.005
-
Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response element. J Biol Chem. 1997 May 30; 272(22):14387-93.
Score: 0.005
-
Role of interferons in demyelinating diseases. J Neural Transm Suppl. 1997; 49:117-23.
Score: 0.005
-
Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology. 1996 Dec; 47(6):1463-8.
Score: 0.005
-
Interferon beta in multiple sclerosis. Clin Immunol Immunopathol. 1996 Oct; 81(1):1-11.
Score: 0.005
-
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. J Neurol. 2016 Jul; 263(7):1418-26.
Score: 0.005
-
Mechanisms of action of interferon-beta in multiple sclerosis. Springer Semin Immunopathol. 1996; 18(1):125-48.
Score: 0.005
-
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. JAMA Neurol. 2015 Dec; 72(12):1458-65.
Score: 0.005
-
Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology. 1995 Dec; 45(12):2173-7.
Score: 0.005
-
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. J Neurol. 2015 Nov; 262(11):2466-71.
Score: 0.004
-
Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology. 1995 Jun; 45(6):1097-100.
Score: 0.004
-
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study. Eur Neurol. 2014; 71(3-4):173-9.
Score: 0.004
-
Nervous system-immune system interactions and their role in multiple sclerosis. Ann Neurol. 1994; 36 Suppl:S29-32.
Score: 0.004
-
Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol. 1993 Jul; 46(1-2):123-8.
Score: 0.004
-
The hu-SCID myasthenic mouse. A new tool for the investigation of seronegative myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21; 681:303-5.
Score: 0.004
-
Interferon beta in multiple sclerosis. Neurology. 1993 Apr; 43(4):641-3.
Score: 0.004
-
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study. J Neurol. 2013 Jul; 260(7):1838-45.
Score: 0.004
-
Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis. J Neuroimmunol. 1993 Mar; 43(1-2):145-9.
Score: 0.004
-
Variability in detection and quantification of interferon ß-1b-induced neutralizing antibodies. J Neuroinflammation. 2012 Jun 15; 9:129.
Score: 0.004
-
Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis. J Neuroimmunol. 1992 Feb; 36(2-3):171-7.
Score: 0.003
-
Multiple sclerosis: additional thoughts. J Neurol Sci. 1992 Feb; 107(2):141-4.
Score: 0.003
-
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol. 2011 Dec; 70(6):897-912.
Score: 0.003
-
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler. 2012 Feb; 18(2):181-95.
Score: 0.003
-
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Mult Scler. 2011 Dec; 17(12):1504-13.
Score: 0.003
-
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. Ann Neurol. 1991 Jul; 30(1):42-7.
Score: 0.003
-
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol. 2011 Nov; 26(11):1411-21.
Score: 0.003
-
Interferon ß-1b and glatiramer acetate effects on permanent black hole evolution. Neurology. 2011 Apr 05; 76(14):1222-8.
Score: 0.003
-
Olig1 is expressed in human oligodendrocytes during maturation and regeneration. Glia. 2011 Jun; 59(6):914-26.
Score: 0.003
-
Nervous system-immune system communication. Rev Infect Dis. 1991 Jan-Feb; 13 Suppl 1:S134-7.
Score: 0.003
-
Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Ann Neurol. 1990 Apr; 27(4):366-72.
Score: 0.003
-
Nervous system-immune system interactions. Res Publ Assoc Res Nerv Ment Dis. 1990; 68:67-90.
Score: 0.003
-
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol. 2009 Oct; 8(10):889-97.
Score: 0.003
-
Comparison of sympathetic skin response with quantitative sudomotor axon reflex test in diabetic neuropathy. Muscle Nerve. 1989 May; 12(5):420-3.
Score: 0.003
-
Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler. 2008 Jul; 14(6):809-14.
Score: 0.003
-
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun; 30(6):1102-12.
Score: 0.003
-
Blood lymphocyte beta-adrenergic receptors in multiple sclerosis. Ann N Y Acad Sci. 1988; 540:585-8.
Score: 0.003
-
Immunoregulation in rapidly progressive multiple sclerosis. Ann N Y Acad Sci. 1988; 540:4-12.
Score: 0.003
-
HLA antigens in narcolepsy. Neurology. 1987 Dec; 37(12):1858-60.
Score: 0.003
-
Immunologic aspects of neurological and neuromuscular diseases. JAMA. 1987 Nov 27; 258(20):2970-3.
Score: 0.003
-
A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors. Eur J Immunol. 2007 Apr; 37(4):1139-48.
Score: 0.002
-
Neuroimmunology. N Engl J Med. 1987 Feb 12; 316(7):406-8.
Score: 0.002
-
Autoimmune neuropathies. Ann N Y Acad Sci. 1987; 505:313-8.
Score: 0.002
-
Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2. J Clin Invest. 1986 Aug; 78(2):582-6.
Score: 0.002
-
Patterns and significance of concomitant central and peripheral inflammatory demyelination. Neurol Res. 2006 Apr; 28(3):326-33.
Score: 0.002
-
Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Ann Neurol. 1985 Dec; 18(6):722-5.
Score: 0.002
-
Effect of myasthenia serum and anti-acetylcholine receptor monoclonal antibody on the distributions of T-cell subsets in myasthenia patients and normal subjects. Asian Pac J Allergy Immunol. 1985 Jun; 3(1):30-6.
Score: 0.002
-
Multiple sclerosis: relation of in vitro IgG secretion to T suppressor cell number and function. Neurology. 1984 Sep; 34(9):1155-60.
Score: 0.002
-
Low T8 antigen density on lymphocytes in active multiple sclerosis. Ann Neurol. 1984 Aug; 16(2):242-9.
Score: 0.002
-
Analysis of T regulator cell surface markers and functional properties in multiple sclerosis. J Neuroimmunol. 1984 Apr; 6(2):93-103.
Score: 0.002
-
T regulator cell surface antigens in multiple sclerosis. Ann N Y Acad Sci. 1984; 436:247-53.
Score: 0.002
-
Immunoregulation in multiple sclerosis. Ann N Y Acad Sci. 1984; 436:133-9.
Score: 0.002
-
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003 Nov 25; 61(10):1332-8.
Score: 0.002
-
Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol Clin. 1983 Aug; 1(3):765-82.
Score: 0.002
-
Interferons in relapsing remitting multiple sclerosis. Lancet. 2003 May 24; 361(9371):1822; author reply 1823-4.
Score: 0.002
-
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol. 1983; 59(4):255-61.
Score: 0.002
-
Issues and practices in multiple sclerosis. Neurorehabil Neural Repair. 2002 Dec; 16(4):307-20.
Score: 0.002
-
A biochemically distinct sub-population of neurons in the human substantia gelatinosa. Study with G-6-PD histochemistry. J Neurol Sci. 1982 Aug; 55(2):175-83.
Score: 0.002
-
Muscle acid protease activity in amyotrophic lateral sclerosis: correlation with clinical and pathologic features. Neurology. 1982 Aug; 32(8):901-3.
Score: 0.002
-
Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis. Proc Natl Acad Sci U S A. 1982 May; 79(10):3330-4.
Score: 0.002
-
Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann Neurol. 1982 May; 11(5):456-62.
Score: 0.002
-
Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid. Clin Exp Immunol. 1982 Apr; 48(1):25-36.
Score: 0.002
-
Multiple sclerosis: current concepts and management. Hosp Pract (Off Ed). 1982 Feb; 17(2):81-9.
Score: 0.002
-
Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol. 1982 Feb; 11(2):177-81.
Score: 0.002
-
Immunology of amyotrophic lateral sclerosis. Adv Neurol. 1982; 36:395-402.
Score: 0.002
-
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci. 2002 Jan 01; 22(1):123-32.
Score: 0.002
-
Generation of suppressor cells by aggregated human globulin. Clin Exp Immunol. 1981 Feb; 43(2):351-6.
Score: 0.002
-
Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol. 1981 Jan; 9(1):34-41.
Score: 0.002
-
Comparison between antibody-induced modulation of suppressor cells and suppressor cell changes in multiple sclerosis. Trans Am Neurol Assoc. 1981; 106:233-6.
Score: 0.002
-
Cell-mediated immunity in idiopathic polyneuritis. Ann Neurol. 1981; 9 Suppl:65-9.
Score: 0.002
-
Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med. 1980 Sep 25; 303(13):713-7.
Score: 0.002
-
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature. 1980 Sep 25; 287(5780):335-7.
Score: 0.002
-
Immunoregulation in multiple sclerosis. Ann Neurol. 1980 Sep; 8(3):237-40.
Score: 0.002
-
Reduced T-lymphocyte cell reactivity as a function of human aging. Cell Immunol. 1980 Aug 15; 54(1):184-92.
Score: 0.002
-
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev. 1980 Apr; 12(4):331-7.
Score: 0.002
-
Huntington's disease: abnormality of lymphocyte capping. Ann Neurol. 1979 Nov; 6(5):447-50.
Score: 0.001
-
Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proc Natl Acad Sci U S A. 1979 Sep; 76(9):4632-5.
Score: 0.001
-
Suppressor cell function in man: evidence for altered sensitivity of responder cells with age. Clin Immunol Immunopathol. 1979 Jun; 13(2):119-24.
Score: 0.001
-
Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site. Neurology. 1979 Mar; 29(3):291-6.
Score: 0.001
-
Mitogen responsiveness and suppressor cell function in multiple sclerosis. Influence of age and disease activity. Neurology. 1978 Oct; 28(10):999-1003.
Score: 0.001
-
Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology. 1978 Sep; 28(9 Pt 2):106-10.
Score: 0.001
-
Suppressor cell function in multiple sclerosis. Ann Immunol (Paris). 1978 Feb-Mar; 129(2-3):159-70.
Score: 0.001
-
Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis. Trans Am Neurol Assoc. 1978; 103:191-3.
Score: 0.001
-
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol. 1978 Jan; 9(1):134-41.
Score: 0.001
-
Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology. 1996 Jul; 47(1):129-39.
Score: 0.001
-
Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med. 1976 Mar 25; 294(13):694-8.
Score: 0.001
-
Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology. 1996 Jan; 46(1):12-8.
Score: 0.001
-
Proceedings: Immunogenetic aspects of demyelinating disease. Neurology. 1975 May; 25(5):489.
Score: 0.001
-
Neutralizing antibodies to poliovirus and mumps virus in amyotrophic lateral sclerosis. J Neurol Sci. 1974 Dec; 23(4):537-40.
Score: 0.001
-
Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol. 1974 Sep; 31(3):192-6.
Score: 0.001
-
Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci. 1974 Aug; 22(4):419-28.
Score: 0.001
-
The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann Neurol. 1993 Jul; 34(1):48-56.
Score: 0.001
-
The function of the CD2 protein is abnormal in multiple sclerosis. J Autoimmun. 1991 Jun; 4(3):479-91.
Score: 0.001
-
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol. 1991 Apr; 32(1):67-74.
Score: 0.001
-
Idiopathic polyneuritis (Landry-Guillain-Barré-Strohl syndrome) and experimental allergic neuritis: a comparison. Res Publ Assoc Res Nerv Ment Dis. 1971; 49:156-77.
Score: 0.001
-
Etiologic correlations between idiopathic polyneuritis and multiple sclerosis: therapeutic implications. Mod Treat. 1970 Sep; 7(5):903-17.
Score: 0.001
-
Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis. Trans Am Neurol Assoc. 1969; 94:54-8.
Score: 0.001
-
Comparison of T8+ cell-mediated suppressor and cytotoxic functions in multiple sclerosis. J Neuroimmunol. 1986 Sep; 12(3):215-24.
Score: 0.001
-
Paraneoplastic myelopathy: antibodies against protein in normal spinal cord and underlying neoplasm. Lancet. 1985 Jul 06; 2(8445):49-50.
Score: 0.001
-
Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humans. Mech Ageing Dev. 1983 Sep; 23(1):11-9.
Score: 0.000
-
Age-related changes in in vitro immunoglobulin secretion: comparison of responses to T-dependent and T-independent polyclonal activators. Cell Immunol. 1982 Dec; 74(2):398-403.
Score: 0.000
-
Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transfer. Ann N Y Acad Sci. 1981; 377:97-109.
Score: 0.000
-
C-6 glioma growth in rats: suppression with a beta-adrenergic agonist and a phosphodiesterase inhibitor. Ann Neurol. 1980 Oct; 8(4):447-9.
Score: 0.000
-
Autosomal dominant cerebrovascular amyloidosis: properties of peripheral blood lymphocytes. Ann Neurol. 1980 May; 7(5):436-40.
Score: 0.000
-
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol. 1979 Apr; 5(4):338-42.
Score: 0.000
-
A study of B and T cells in multiple sclerosis. Neurology. 1975 May; 25(5):444-7.
Score: 0.000
-
The thymus gland in elderly patients with myasthenia gravis. Neurology. 1975 Mar; 25(3):294-5.
Score: 0.000
-
Parainfluenza, histocompatibility, and multiple sclerosis. Association of parainfluenza antibodies and histocompatibility types in MS and optic neuritis. Arch Neurol. 1974 Apr; 30(4):327-9.
Score: 0.000
-
The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15; 183:308-15.
Score: 0.000